| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 08/12/2009 | EP2086947A1 Pyrimidines and their use as cxcr2 receptor antagonists |
| 08/12/2009 | EP2086946A2 Rosuvastatin dehydroabietylamine salt |
| 08/12/2009 | EP2086945A2 Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof |
| 08/12/2009 | EP2086329A2 Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance |
| 08/12/2009 | CN101506177A 2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as JAK kinases inhibitors |
| 08/12/2009 | CN101506176A 2-anilino-4-aminoalkyleneaminopyrimidines |
| 08/12/2009 | CN101506175A 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase C-alpha |
| 08/12/2009 | CN101506168A Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate |
| 08/12/2009 | CN101503402A 2-aniline pyrimidine derivative, as well as preparation and uses thereof |
| 08/12/2009 | CN100526982C Positive-working photoimageable bottom antireflective coating |
| 08/12/2009 | CN100526308C Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 08/12/2009 | CN100526298C Amide derivative and medicine |
| 08/12/2009 | CN100525768C Novel compounds |
| 08/11/2009 | US7572911 Azotization of 5-amino-3-t-butyl-4-cyanopyrazole, then reacting with couplers and alkylation or arylation, to form azo dyes, used as inks having colorfastness; liquid crystal displays and plasma display panels; excellent color reproducibility |
| 08/11/2009 | US7572817 Carboxypeptidase U inhibitors; thrombosis, atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases; e.g. 2-[(6-Aminopyridin-3-yl)methyl]-3-mercapto-5-[3-(pyrrolidin-1-ylcarbonyl)phenyl]pentanoic acid |
| 08/11/2009 | US7572816 Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 08/11/2009 | US7572802 For central nervous system diseases, in particular Parkinson's disease, Extra Pyramidal Syndrome, restless legs syndrome and attention deficit hyperactivity disorder |
| 08/11/2009 | US7572798 Combi-molecules having signal transduction inhibitory properties and DNA damaging properties |
| 08/11/2009 | US7572793 Tau protein kinase 1 inhibitors; treatment for neurodegenerative disorders; Alzheimer's Disease, Parkinson's disease, Pick's Disease, vision defects; antiischemic, antidiabetic, anticarcinogenic, antitumor agents, antidepressants |
| 08/11/2009 | CA2368688C Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 08/06/2009 | WO2009097578A1 Oxim derivatives as hsp90 inhibitors |
| 08/06/2009 | WO2009096667A2 Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same |
| 08/06/2009 | WO2009096526A1 Carboxylic acid compound or salt thereof |
| 08/06/2009 | WO2009096198A1 Novel biaryl derivative |
| 08/06/2009 | WO2009095773A2 Novel heterocycles |
| 08/06/2009 | WO2009094867A1 Nitrogenous heterocyclic compound with insecticidal activity and its preparation and use |
| 08/06/2009 | WO2009094831A1 Heteroaromatic compounds, the preparation method and the use thereof |
| 08/06/2009 | WO2009024323A3 Process for preparing pyrimidine derivatives |
| 08/06/2009 | WO2008103354A3 Modulators of acetyl-coenzyme a carboxylase and methods of use thereof |
| 08/06/2009 | US20090197902 Use of Pyrimidine Compounds in the Preparation of Parasiticides |
| 08/06/2009 | US20090197901 Variolin derivatives and their use as antitumor agents |
| 08/06/2009 | CA2715069A1 Novel heterocycles |
| 08/06/2009 | CA2713658A1 Oxim derivatives as hsp90 inhibitors |
| 08/06/2009 | CA2712819A1 Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same |
| 08/05/2009 | EP1631292B1 4-anilino-quinazoline derivatives as antiproliferative agents |
| 08/05/2009 | EP1473289B1 Preventives or remedies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds |
| 08/05/2009 | EP1383731B1 Biaryl compounds as serine protease inhibitors |
| 08/05/2009 | EP1249233B9 Npyy5 antagonists |
| 08/05/2009 | CN101501007A Quinazoline derivative |
| 08/05/2009 | CN100522952C Insecticidal phthalamide derivatives |
| 08/05/2009 | CN100522172C Non-sedating barbiturate compounds as neuroprotective agents |
| 08/05/2009 | CN100522171C 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 08/04/2009 | US7569678 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 08/04/2009 | US7569601 Such as (2E)-3-{4-[1-ethyl-2,2-bis(4-hydroxyphenyl)ethenyl]phenyl}-2-propenoic acid; for selective estrogen receptor modulation; menopausal or postmenopausal disorders, vasomotor symptoms, urogenital or vulvar vaginal atrophy, atrophic vaginitis, female sexual dysfunction, breast cancer, osteoporosis |
| 08/04/2009 | US7569578 Heterocyclic anti-migraine agents |
| 08/04/2009 | US7569577 (2S)-1-[4-({4-[3-chloro-2-fluoroanilino]-6-methoxyquinazolin-7-yl}oxy)piperidin-1-yl]-1-oxopropan-2-ol; antiproliferative agents; for treatment of cancers mediated by erbB receptor EGFR tyrosine kinases; psoriasis |
| 08/04/2009 | US7569575 Synthesis of locked nucleic acid derivatives |
| 08/04/2009 | CA2425984C 2-pyrimidinyloxy-n-aryl-benzylamine derivatives, their preparation processes and uses |
| 08/04/2009 | CA2356212C Crystalline bis[(e)-7- [ 4-(4- fluorophenyl)- 6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin -5-yl] (3r,5s)-3, 5-dihydroxyhept -6-enoic acid]calcium salt |
| 07/30/2009 | WO2009094528A1 TRICYCLIC COMPOUNDS AS MODULATORS OF TNF-α SYNTHESIS AND AS PDE4 INHIBITORS |
| 07/30/2009 | WO2009094442A2 5-fluoro pyrimidine derivatives as fungicides |
| 07/30/2009 | WO2009092702A2 ((2s,4r)-4,6-dihydroxytetrahydro-2h-pyran-2-yl)methyl carboxylate and process for the production employing a 2-deoxyribose-5-phosphate aldolase |
| 07/30/2009 | WO2009067600A3 Biaryl pde4 inhibitors for treating inflammation |
| 07/30/2009 | US20090192122 Inflammatory cytokine release inhibitor |
| 07/30/2009 | US20090188305 Reference standard for characterization of rosuvastatin |
| 07/30/2009 | CA2713009A1 ((2s,4r)-4,6-dihydroxytetrahydro-2h-pyran-2-yl)methyl carboxylate and process for the production thereof |
| 07/30/2009 | CA2712777A1 5-fluoro pyrimidine derivatives as fungicides |
| 07/29/2009 | EP2081914A2 Crystalline form of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2h)-pyrimidinyl]-4-fluoro-n-[[methyl-(1-methyl-ethyl)amino]sulphonyl]benzamide |
| 07/29/2009 | EP1701944B1 2-(amino-substituted)-4-aryl pyramidines and related compounds useful for treating inflammatory diseases |
| 07/29/2009 | EP1686119B1 Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors |
| 07/29/2009 | EP1678166B1 Protein kinase inhibitors |
| 07/29/2009 | EP1268443B1 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 07/29/2009 | CN101495462A Pyrimidine derivatives and their use as pesticides |
| 07/29/2009 | CN101495461A Novel HIV reverse transcriptase inhibitors |
| 07/29/2009 | CN101495460A HSP90 inhibitor |
| 07/29/2009 | CN101492425A Compounds of PARP restrainer |
| 07/29/2009 | CN101492416A Compounds effecting glucokinase |
| 07/29/2009 | CN100519540C S-DABO compound, synthesizing method and usage |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/28/2009 | US7566782 Process for the preparation of rosuvastatin |
| 07/28/2009 | US7566730 Substituted aminoethers for the treatment of Alzheimer's disease |
| 07/28/2009 | US7566724 Glycine derivative and use thereof |
| 07/28/2009 | US7566723 1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use |
| 07/28/2009 | US7566453 Methods for treating melanomas |
| 07/28/2009 | CA2472008C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 07/23/2009 | WO2009091962A1 A novel intermediate for the preparation of paliperidone |
| 07/23/2009 | WO2009091732A1 Compounds for the treatment of metabolic disorders |
| 07/23/2009 | WO2009090661A1 6.7-dialkoxy ouinazoline derivatives useful for treatment of cancer related disorders |
| 07/23/2009 | WO2009089851A1 Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments |
| 07/23/2009 | WO2009013348A3 Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions |
| 07/23/2009 | WO2009002808A3 Quinazolinone compounds and methods of use thereof |
| 07/23/2009 | WO2008103351A3 Heterocyclic aspartyl protease inhibitors |
| 07/23/2009 | US20090186913 Tetrahalogenated compounds useful as inhibitors of angiogenesis |
| 07/23/2009 | US20090186912 Anti-infective agents and uses thereof |
| 07/23/2009 | US20090186911 (RS)-S-[3-({[6-Bromo-4-(isopropylamino)quinazolin-7-yl]oxy}methyl)phenyl] N-(ethoxycarbonyl)-S-ethylsulphoximide, used for the treatment of chronic inflammatory diseases, such as rheumatoid arthritis, Crohn's disease, asthma and multiple sclerosis |
| 07/23/2009 | US20090186890 Pharmaceutical Formulation of Iressa Comprising a Water-Soluble Cellulose Derivative |
| 07/23/2009 | US20090186881 1(R)-1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-[4-(tetrahydropyran-4-yl)-piperazin-1-yl]-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl); calcitonin gene related peptide antagonist; analgesic, antidiabetic agent; migraine or cluster headaches, non-insulin-dependent diabetes |
| 07/23/2009 | CA2712367A1 Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments |
| 07/23/2009 | CA2711737A1 6,7-dialkoxy quinazoline derivatives useful for treatment of cancer related disorders |
| 07/22/2009 | EP2080744A1 Reaction reagent for trifluoromethylation |
| 07/22/2009 | EP2079714A1 Hydrates of 2-chloro-5-ý3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoro-methyl)-1-(2h)-pyrimidinyl¨-4-fluoro-n-ýýmethyl-(1-methylethyl)-amino¨sulphonyl¨benzamide |
| 07/22/2009 | EP2079713A1 Process for synthesis of phenoxy diaminopyrimidine derivatives |
| 07/22/2009 | EP2079712A2 An improved process for preparing rosuvastatin calcium |
| 07/22/2009 | EP2079711A2 2-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as p2y12 receptor antagonists |
| 07/22/2009 | EP1644337B1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 07/22/2009 | EP1477481B1 Process for producing quinazolin-4-one derivative |
| 07/22/2009 | EP1169293B1 Liquid crystal compounds |
| 07/22/2009 | CN101490016A 2,4-substituted quinazolines as lipid kinase inhibitors |
| 07/22/2009 | CN101490015A 瑞舒伐他汀锌盐 Rosuvastatin zinc salt |
| 07/22/2009 | CN101486685A Microwave extracting process for 4(3H) quinazolone in dyers woad leaf |